Esco Lifesciences

Esco Lifesciences Group supplies advanced technologies, products, and services tailored for life sciences and healthcare sectors. It facilitates academic research, clinical practice, and biopharmaceutical development and manufacturing.

Xiangliang Lin

Deputy CEO and Executive Director

Low Yae-Foong

Co-Founder, COO and Executive Director

Lim Lay Yew

Co-Founder and Executive Director

4 past transactions

Allwin Medical Devices

Corporate Round in 2025
Allwin Medical Devices is a manufacturer specializing in a broad range of medical devices. Its portfolio spans several critical areas, including women's health, IVF, urology, gastroenterology, and interventional radiology. The company's product offerings are extensive and diverse, encompassing ureteral stents, catheters, ovum pickup needles, feeding devices, dilators, and drainage systems, among others. Allwin Medical Devices is committed to delivering high-quality products, upholding integrity, and maintaining transparency in all its operations.

MicrofluidX

Seed Round in 2022
MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Roslin Technologies

Series A in 2022
Roslin Technologies develops stem cell technology to advance cultivated meat, with a focus on animal pluripotent stem cells, including perpetually self-renewing induced pluripotent stem cells, to enable scalable production. Its licensable cell lines are designed for high performance and scalability to support the commercial viability of cultivated meat producers and food companies across North America, Europe, and Asia. By delivering advanced cellular platforms, the company aims to reduce production costs and accelerate market entry, with a mission to improve protein production through disruptive technologies.

Dongyun Medical

Corporate Round in 2021
Dongyun Medical is a developer and manufacturer of specialized medical equipment and laboratory consumables for assisted reproduction. The company focuses on research and development and industrialization of culture media and consumables used in human assisted reproduction, including embryo culture solutions, micromanipulation pipettes, cryopreservation kits, and sperm processing reagents. It serves fertility clinics and reproductive medicine laboratories, supporting in vitro fertilization workflows, maintaining biological integrity, and ensuring compatibility with clinical-grade equipment through sterile packaging and standardized products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.